Anti-Inhibitor Coagulant Complex: Side Effects, Uses & Monitoring
FEIBA is an Anti-Inhibitor Coagulant Complex indicated for use in hemophilia A and B patients with inhibitors for: Control and prevention of bleeding episodes Perioperative management Routine prophylaxis to prevent or re
- Data source
- FDA labeling via NIH DailyMed (label 752604e5…)
- Label version
- current
- Last reviewed
- 2026
Reported adverse reactions
Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.
No structured frequency data available in current labeling. Consult the official label.
Labeled uses (from FDA prescribing information)
FEIBA is an Anti-Inhibitor Coagulant Complex indicated for use in hemophilia A and B patients with inhibitors for: Control and prevention of bleeding episodes Perioperative management Routine prophylaxis to prevent or reduce the frequency of bleeding episodes. FEIBA is not indicated for the treatment of bleeding episodes resulting from coagulation factor deficiencies in the absence of inhibitors to coagulation factor VIII or coagulation factor IX.
Conditions associated with Anti-Inhibitor Coagulant Complex in labeling
Frequently Asked Questions
What is Anti-Inhibitor Coagulant Complex used for?
FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.
What are the most commonly reported side effects of Anti-Inhibitor Coagulant Complex?
Current labeling for this ingredient does not include a structured frequency table that we can reproduce. Review the official label linked below.
Does Anti-Inhibitor Coagulant Complex require lab monitoring?
Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Anti-Inhibitor Coagulant Complex.
Where does this information come from?
All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.
Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.